Marian Gaviola is a pharmacist who is specialized in Critical Care in Fort Worth, Texas. Patients can reach her at 3500 Camp Bowie Blvd, Fort Worth or contact her on 817-735-2252. Active license number of Marian Gaviola is 57095 for Critical Care in Texas. Marian Gaviola is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
Marian Gaviola speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Marian Gaviola
Specialization:
Critical Care
Credentials:
PHARMD
Gender:
Female
Location:
3500 Camp Bowie Blvd, Fort Worth, Texas, 76107-2644
Phone:
817-735-2252
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Marian Gaviola are as mentioned below.
NPI Number:
1659907517
NPI Enumeration Date:
22 Mar, 2020
NPI Last Update On:
22 Mar, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Marian Gaviola are as mentioned below.
Specialization
License Number
State
Status
Critical Care
57095
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3500 Camp Bowie Blvd, Fort Worth, Texas
Zip:
76107-2644
Phone Number:
--
Fax Number:
--
Patients can reach Marian Gaviola at 3500 Camp Bowie Blvd, Fort Worth, Texas or can call on phone at 817-735-2252.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.